GlassScriptPhysician profile
Sasha Wainstein
NPI 1437196888
$2,263.41
in general payments reported to CMS, 2019-2025
19 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $290 · 2021: $592 · 2022: $615 · 2023: $166 · 2024: $44.17 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $504.01 | 2019-2025 | Xtandi, Myrbetriq |
| Urovant Sciences INC | $377.08 | 2021-2022 | |
| Pfizer INC. | $323.78 | 2019-2025 | |
| Janssen Biotech, INC. | $228.90 | 2019-2023 | |
| Myovant Sciences INC. | $186.75 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $162.63 | 2023-2025 | Gemtesa, Orgovyx |
| Amgen INC. | $159.73 | 2019-2020 | |
| Blue Earth Diagnostics | $55.26 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $36.71 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.99 | 2019 | |
| Merck Sharp & Dohme LLC | $30.84 | 2019 | |
| Abbvie INC. | $25.26 | 2025 | |
| Verity Pharmaceuticals INC. | $24.60 | 2021 | |
| Boston Scientific Corporation | $23.39 | 2019 | |
| Axonics, INC. | $22.71 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar Pharmaceuticals, INC. | $22.04 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.45 | 2020 | |
| Travere Therapeutics, INC. | $14.66 | 2019 | |
| Allergan, INC. | $13.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sasha Wainstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.